Company: RSKD
Filing Date: 2025-03-06
Form Type: 20-F
Source: 0001851112-25-000006
Chunk: 132

Company: RISKIFIED LTD.
Filing Date: 2025-03-06
Form: 20-F
Item: Item 6
Chunk 132
---
423 Component”).

The maximum aggregate number of Class A ordinary shares that are available for sale under the ESPP is 3,742,961, or the ESPP Share Pool, subject to adjustments as provided for in the ESPP. In addition, on the first day of each calendar year beginning on January 1, 2022 and ending on and including

January 1, 2031, the ESPP Share Pool shall be increased by that number of our Class A ordinary shares equal to the lesser of: (i) 1% of the total number of Class A ordinary shares outstanding as of the last day of the immediately preceding calendar year (calculated on a fully diluted as-converted basis); and (ii) such smaller number of Class A ordinary shares as may be determined by our board of directors. In no event will more than 3,742,961 Class A ordinary shares be available for issuance under the Section 423 Component.

As of December 31, 2024, the ESPP Share Pool consisted of 3,742,961 Class A ordinary shares. In accordance with (ii) above, our board of directors has determined not to increase the ESPP Share Pool as of January 1, 2025.

Unless otherwise determined by our board of directors, the compensation committee of our board of directors will administer the ESPP and has the authority to interpret the terms of the ESPP and determine eligibility under the ESPP and applicable law.

C. Board Practices

Corporate Governance Practices

In addition to NYSE listing rules and applicable provisions of U. S. securities laws, as an Israeli company, we are subject to various corporate governance requirements under the Companies Law related to the appointment of external directors (or, to the extent applicable, the provisions permitting us to opt-out of the requirement to appoint external directors), the composition of the audit committee and compensation committee of the board of directors, appointment of an internal auditor and certain approvals of interested party transactions.

As we are a “foreign private issuer” (as such term is defined in Rule 3b-4 under the Exchange Act), we are permitted to comply with certain Israeli corporate governance practices instead of the corporate governance rules of the NYSE, provided that we disclose which requirements we are not following and the equivalent Israeli requirement. As a result, we are exempt from, among other things, the rules prescribing the furnishing and contents of proxy statements. In addition, our officers, directors and principal shareholders are exempt from the reporting and short-swing profit and recovery